List of Excipients in API acoramidis hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing acoramidis hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| BridgeBio Pharma Inc | ATTRUBY | acoramidis hydrochloride | 82228-712 | CELLULOSE, MICROCRYSTALLINE | 2031-11-22 |
| BridgeBio Pharma Inc | ATTRUBY | acoramidis hydrochloride | 82228-712 | CROSCARMELLOSE SODIUM | 2031-11-22 |
| BridgeBio Pharma Inc | ATTRUBY | acoramidis hydrochloride | 82228-712 | FERROSOFERRIC OXIDE | 2031-11-22 |
| BridgeBio Pharma Inc | ATTRUBY | acoramidis hydrochloride | 82228-712 | GLYCERYL MONO- AND DICAPRYLOCAPRATE | 2031-11-22 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for acoramidis hydrochloride
Excipient focus: CELLULOSE, MICROCRYSTALLINE
acoramidis hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| BridgeBio Pharma Inc | acoramidis hydrochloride | 82228-712 |
| >Company | >Ingredient | >NDC |
acoramidis hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
acoramidis hydrochloride drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| BridgeBio Pharma Inc | acoramidis hydrochloride | 82228-712 |
| >Company | >Ingredient | >NDC |
acoramidis hydrochloride drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
acoramidis hydrochloride drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| BridgeBio Pharma Inc | acoramidis hydrochloride | 82228-712 |
| >Company | >Ingredient | >NDC |
acoramidis hydrochloride drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONO- AND DICAPRYLOCAPRATE
acoramidis hydrochloride drug variants containing GLYCERYL MONO- AND DICAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| BridgeBio Pharma Inc | acoramidis hydrochloride | 82228-712 |
| >Company | >Ingredient | >NDC |
acoramidis hydrochloride drug variants not containing GLYCERYL MONO- AND DICAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
acoramidis hydrochloride drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| BridgeBio Pharma Inc | acoramidis hydrochloride | 82228-712 |
| >Company | >Ingredient | >NDC |
acoramidis hydrochloride drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
acoramidis hydrochloride drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| BridgeBio Pharma Inc | acoramidis hydrochloride | 82228-712 |
| >Company | >Ingredient | >NDC |
acoramidis hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
acoramidis hydrochloride drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| BridgeBio Pharma Inc | acoramidis hydrochloride | 82228-712 |
| >Company | >Ingredient | >NDC |
acoramidis hydrochloride drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER
acoramidis hydrochloride drug variants containing POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| BridgeBio Pharma Inc | acoramidis hydrochloride | 82228-712 |
| >Company | >Ingredient | >NDC |
acoramidis hydrochloride drug variants not containing POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
acoramidis hydrochloride drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| BridgeBio Pharma Inc | acoramidis hydrochloride | 82228-712 |
| >Company | >Ingredient | >NDC |
acoramidis hydrochloride drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
acoramidis hydrochloride drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| BridgeBio Pharma Inc | acoramidis hydrochloride | 82228-712 |
| >Company | >Ingredient | >NDC |
acoramidis hydrochloride drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
acoramidis hydrochloride drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| BridgeBio Pharma Inc | acoramidis hydrochloride | 82228-712 |
| >Company | >Ingredient | >NDC |
acoramidis hydrochloride drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
acoramidis hydrochloride drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| BridgeBio Pharma Inc | acoramidis hydrochloride | 82228-712 |
| >Company | >Ingredient | >NDC |
acoramidis hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch